Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Combo-Product Sponsors Gain Some Favored Changes In Final Post-Market Reporting Rule

Executive Summary

US FDA’s final rule includes several clarifications about its scope and definitions, and includes some additional reporting requirements.

You may also be interested in...

US FDA Delays Combo Safety Guidance Deadlines Again After Industry Feedback

Industry concerns they won’t meet a deadline from the FDA to comply with a combination products safety reporting requirement has led the agency to again push back a couple of implementation deadlines by a year.

Combination Products: US FDA Extends Safety-Reporting Deadline

After major post-market safety reporting rule in 2016, guidance adds context for companies developing combination products. FDA also extends compliance deadlines in many cases until 2019.

US FDA Extends Safety-Reporting Deadline For Certain Combination Products, Issues Guidance

After issuing a major combination product post-market safety reporting rule at the end of 2016, US FDA released guidance to add context for companies developing the products. The agency has also extended compliance deadlines in many cases until 2019.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts